Predictors of Complete Remission in Differentiated Thyroid Cancer: A Study from the Nuclear Medicine Department of Ibn Rochd Hospital in Casablanca, Morocco

分化型甲状腺癌完全缓解的预测因素:来自摩洛哥卡萨布兰卡伊本·鲁什德医院核医学科的一项研究

阅读:1

Abstract

BACKGROUND: Differentiated thyroid cancers (DTCs) are the most common endocrine malignancies. Although they are generally associated with a favorable prognosis, some patients do not achieve complete remission after treatment. This study aimed to identify predictive factors for complete remission among Moroccan patients with DTCs. PATIENTS AND METHODS: We retrospectively reviewed the medical records of patients diagnosed with DTCs between 2004 and 2012 and followed at the Nuclear Medicine Department of Ibn Rochd Hospital. Associations between complete remission and various epidemiological and histopathological factors were assessed using the chi-square test and logistic regression. RESULTS: A total of 1,366 patients were included. The cohort comprised 89.6% females and 10.4% males, with a sex ratio of 8.5. The mean age at diagnosis was 44 years (range: 14-85 years), and the mean follow-up duration was 125 months. Logistic regression analysis identified the following as significant predictors of complete remission: female sex, age <55 years, papillary thyroid carcinoma, tumor size ≤4 cm, unilaterality, absence of extrathyroidal extension, absence of vascular invasion, undetectable postoperative thyroglobulin (TG) levels, and absence of local or distant involvement. CONCLUSION: Younger age, female sex, favorable histology, and limited tumor burden were associated with a higher likelihood of complete remission in Moroccan patients with DTCs. Identifying these factors is crucial for tailoring treatment strategies and optimizing follow-up, particularly for patients at higher risk of persistent or recurrent disease.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。